✦ LIBER ✦

Economic Evaluation of Treatments for Chronic Hepatitis B

✍ Scribed by Wiens, A.; Venson, R.; Lenzi, L.; Correr, C.J.; Pontarolo, R.

Book ID: 123424342
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 60 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.2210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A systematic review and economic evaluat

A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B

✍ A. Takeda; J. Jones; J. Shepherd; P. Davidson; A. Price 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB

Economic and clinical effects of evaluat

Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C

✍ John B Wong; Gary L Davis; John G McHutchison; Michael P Manns; Janice K Albrech 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Economic evaluation of chronic hepatitis

Economic evaluation of chronic hepatitis B treatments in Taiwan

✍ Laurence Lacey; Rong-Nan Chien; Wan-Long Chuang; Raoh-Fang Pwu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Cost-effectiveness of oral treatments fo

Cost-effectiveness of oral treatments for chronic hepatitis B

✍ Geoffrey M. Dusheiko 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Natural Course, Therapeutic Options and

Natural Course, Therapeutic Options and Economic Evaluation of Therapies for Chronic Hepatitis B

✍ Dr Steven-Huy B. Han 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 160 KB

Economic modeling of treatment in chroni

Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: Promises and limitations

✍ Raymond S. Koff; Leonard B. Seeff 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

The past 3 decades have witnessed remarkable advances in knowledge about viral hepatitis. We have moved from the belief, before the early 1970s, that only two vaguely defined viruses existed (infectious and serum; A and B) to the identification by the mid-1990s of six cloned hepatitis agents (A thro